Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Study of safety, reactogenicity and immunogenicity of two doses of GSK Biologicals' oral live attenuated human rotavirus vaccine co-administered with either oral polio vaccine (OPV) or inactivated polio vaccine (IPV) in healthy infants in South Africa
Rotavirus Vaccine
444563/014 (Rota-014)
NCT00346892
Infections, Rotavirus
Phase 2
 
An annotated case report form is not available for this study. A blank case report form will be provided.
June 2015

Powered by ideaPoint, Inc.